Alembic Pharma receives 4 observations from USFDA for Panelav facility
Posted by
www.biotecnika.org
"The US Food and Drug Administration (USFDA) has conducted an
inspection at Alembic Pharmaceuticals general oral solid formulation
facility located at Panelav from 9-13 March, 2020," the drug firm said
in a filing to the BSE. This was a scheduled inspection, and at the
end of the inspection, the USFDA issued a Form 483 with four
procedural observations.
https://economictimes.indiatimes.com/industry/healthcare/biotech/pharmaceuticals/alembic-pharma-receives-4-observations-from-usfda-for-panelav-facility/articleshow/74647840.cms
Subscribe to:
Post Comments (Atom)
Post a Comment